Your browser doesn't support javascript.
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters.
Piano Mortari, Eva; Pulvirenti, Federica; Marcellini, Valentina; Terreri, Sara; Salinas, Ane Fernandez; Ferrari, Simona; Di Napoli, Giulia; Guadagnolo, Daniele; Sculco, Eleonora; Albano, Christian; Guercio, Marika; Di Cecca, Stefano; Milito, Cinzia; Garzi, Giulia; Pesce, Anna Maria; Bonanni, Livia; Sinibaldi, Matilde; Bordoni, Veronica; Di Cecilia, Serena; Accordini, Silvia; Castilletti, Concetta; Agrati, Chiara; Quintarelli, Concetta; Zaffina, Salvatore; Locatelli, Franco; Carsetti, Rita; Quinti, Isabella.
  • Piano Mortari E; B Cell Unit, Immunology Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Pulvirenti F; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Marcellini V; Reference Centre for Primary Immune Deficiencies, Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome, Italy.
  • Terreri S; Research Biobank, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Salinas AF; B Cell Unit, Immunology Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Ferrari S; B Cell Unit, Immunology Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Di Napoli G; Medical Genetics Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Guadagnolo D; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Sculco E; Department of Experimental Medicine, Policlinico Umberto I Hospital, Sapienza University of Rome, Rome, Italy.
  • Albano C; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Guercio M; B Cell Unit, Immunology Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Di Cecca S; Department of Onco-Haematology, and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Milito C; Department of Onco-Haematology, and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Garzi G; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Pesce AM; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Bonanni L; Reference Centre for Primary Immune Deficiencies, Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome, Italy.
  • Sinibaldi M; Reference Centre for Primary Immune Deficiencies, Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome, Italy.
  • Bordoni V; Department of Onco-Haematology, and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Di Cecilia S; Department of Onco-Haematology, and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Accordini S; FlowJo, BD Life-Sciences-Biosciences, Ashland, OR, United States.
  • Castilletti C; Department of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
  • Agrati C; Department of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
  • Quintarelli C; Department of Onco-Haematology, and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Zaffina S; Department of Onco-Haematology, and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Locatelli F; Occupational Medicine/Health Technology Assessment and Safety Research Unit, Clinical-Technological Innovations Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Carsetti R; Department of Experimental Medicine, Policlinico Umberto I Hospital, Sapienza University of Rome, Rome, Italy.
  • Quinti I; Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Rome, Italy.
Front Immunol ; 14: 1194225, 2023.
Artículo en Inglés | MEDLINE | ID: covidwho-20241313
ABSTRACT

Introduction:

Assessing the response to vaccinations is one of the diagnostic criteria for Common Variable Immune Deficiencies (CVIDs). Vaccination against SARS-CoV-2 offered the unique opportunity to analyze the immune response to a novel antigen. We identify four CVIDs phenotype clusters by the integration of immune parameters after BTN162b2 boosters.

Methods:

We performed a longitudinal study on 47 CVIDs patients who received the 3rd and 4th vaccine dose of the BNT162b2 vaccine measuring the generation of immunological memory. We analyzed specific and neutralizing antibodies, spike-specific memory B cells, and functional T cells.

Results:

We found that, depending on the readout of vaccine efficacy, the frequency of responders changes. Although 63.8% of the patients have specific antibodies in the serum, only 30% have high-affinity specific memory B cells and generate recall responses.

Discussion:

Thanks to the integration of our data, we identified four functional groups of CVIDs patients with different B cell phenotypes, T cell functions, and clinical diseases. The presence of antibodies alone is not sufficient to demonstrate the establishment of immune memory and the measurement of the in-vivo response to vaccination distinguishes patients with different immunological defects and clinical diseases.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Inmunodeficiencia Variable Común / COVID-19 Tipo de estudio: Estudio de cohorte / Estudio experimental / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Humanos Idioma: Inglés Revista: Front Immunol Año: 2023 Tipo del documento: Artículo País de afiliación: Fimmu.2023.1194225

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Inmunodeficiencia Variable Común / COVID-19 Tipo de estudio: Estudio de cohorte / Estudio experimental / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Humanos Idioma: Inglés Revista: Front Immunol Año: 2023 Tipo del documento: Artículo País de afiliación: Fimmu.2023.1194225